Ireland set a decade-high in life sciences and health tech investment for 2024, securing €491.3 million across 89 VC deals, according to a PitchBook-backed report released on December 2, 2025.

In September 2025, patients at 31 Irish hospitals began accessing appointment details and personal health information through the HSE Health App, with plans for a broader rollout as more public hospitals are integrated.

A standout 2025 development saw Dublin-based FIRE1 raise €115 million in a late-stage round to advance its Norm heart failure management system, which uses an implanted sensor and cloud data to monitor fluid levels.

Ireland remains a leading MedTech exporter, ranking second in Europe with exports around €16 billion annually (about 14% of total exports) and hosting over 700 life sciences and health tech firms, including more than 400 home-grown companies and nine of the world’s top 10 MedTech multinationals.

Enterprise Ireland was the world’s most active investor in life sciences and health tech in 2024, participating in 60 deals, highlighting strong government support for the sector.

The Disruptive Technologies Innovation Fund allocated €454 million of its €500 million total, with €298 million directed to 68 health and wellbeing projects, underscoring substantial public funding alongside private investment.

In 2024, late-stage and venture-growth deals made up 46% of total volume, more than doubling the share seen in 2014, signaling a maturing, growth-oriented ecosystem.